Testagen Research Overview (also known as Khavinson testis peptide, Testagen Lys-Glu-Asp-Trp)
A peptide studied for testosterone pathway support, libido maintenance, and vitality marker regulation in male research models. Often included in male optimization and hormonal longevity research stacks alongside Testoluten and Libidon.
What Is Testagen?
Testagen is a tetrapeptide bioregulator developed by Professor Vladimir Khavinson targeting testicular tissue — specifically the Leydig cells (testosterone-producing) and Sertoli cells (spermatogenesis-supporting) of the testis. It is designed to restore normal testicular cell function that declines with aging.
Testicular Aging
Testosterone production declines by approximately 1–2% per year after age 30, driven by progressive Leydig cell loss, reduced LH receptor sensitivity, and impaired intratesticular signaling. Sertoli cell function also declines, contributing to age-related reductions in sperm quality and fertility. These changes underlie male hypogonadism of aging, manifesting as fatigue, reduced libido, loss of muscle mass, and increased fat.
Research Applications
Animal studies have demonstrated improved testicular histology in aged animals — with better preservation of Leydig cell numbers, improved Sertoli cell architecture, and higher intratesticular testosterone concentrations. Russian clinical research documents improved testosterone levels and sperm quality parameters in men receiving Testagen as part of anti-aging bioregulator protocols. It is often combined with Libidon and Prostamax for comprehensive male reproductive health support.
Quick Reference
| Literature-Reported Dose Range | 1–2 mg per injection |
| Literature-Reported Frequency | Once daily |
| Literature-Reported Cycle Length | 20–30 days per course |
| Literature-Reported Washout | 2–3 courses per year; minimum 2 months off, 2–3× per year |
| Storage | Lyophilized -20°C, Reconstituted 2-8°C |
| Sites Reported in Studies | SubQ: abdomen, thigh, or upper arm |
| Timing | AM or PM, consistent daily timing |
Research Indications
Thyroid
Thyroid Function Optimization
May enhance T3/T4 thyroid hormone production through TSH modulation.
TSH Stimulation
Research suggests potential stimulation of thyroid-stimulating hormone release from anterior pituitary.
Hormonal
Testosterone Support
Indirect testosterone support through thyroid function optimization - hypothyroidism correlates with reduced testosterone.
Pituitary Function
Proposed to stimulate anterior pituitary function and overall endocrine regulation.
Longevity
Bioregulator Therapy
Part of Khavinson's 40-year research program on peptide geroprotectors for age-related decline.
Epigenetic Regulation
Proposed to interact with DNA and histones to modulate gene expression in target tissues.
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| Standard protocol | 1–2 mg daily | Once daily | SubQ |
| Oral supplement | 1-2 capsules | 1-2x daily | Oral |
Timing
Recommended administration window: morning preferred. Typical onset: 4-12 weeks for hormonal effects.
Peptide Interactions
Both are Khavinson bioregulators - Epitalon targets pineal function while Testagen targets anterior pituitary. Commonly used together in Russian anti-aging protocols.
Complementary bioregulators - Pinealon supports pineal/brain function while Testagen supports pituitary-gonadal axis.
Both are Khavinson bioregulators with different targets (thymus vs pituitary). No known negative interactions.
Both affect pituitary function - CJC-1295 stimulates GH release while Testagen may affect TSH. Monitor for hormonal changes.
Different pituitary targets - Ipamorelin stimulates GH via ghrelin receptor, Testagen targets TSH pathways.
No direct interaction - work through completely different mechanisms (tissue repair vs endocrine regulation).
Testagen may affect TSH and thyroid hormone levels - monitor thyroid function closely if on thyroid medications.
Both affect testosterone levels through different mechanisms. Monitor hormone levels if combining.
Reported Research Timeline
01Weeks 1–4 (reported in cited studies): subtle or no effects initially
02Weeks 4–8 (reported in cited studies): potential thyroid optimization
03Weeks 8–12 (reported in cited studies): full endocrine effects may manifest
04Effects are subtle - this is a bioregulator, not a hormone
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
No human clinical trials - preclinical data only
Not Recommended with thyroid cancer or hyperthyroidism
Consult healthcare provider before use
Seek Medical Attention If:
Quality Indicators
Verified Marker
White powder, clear solution
Proper appearance indicates quality peptide.
Acceptable Range
Limited Western research
Most data from Russian bioregulator programs.
Quality Concern
Discoloration or particles
Indicates degradation - do not use.
Research Citations
- Peptide bioregulators: A new class of geroprotectors
Khavinson VKh, Kuznik BI, Ryzhak GA, 2013, Advances in Gerontology - Peptide bioregulator efficacy in the correction of reduced thyroid gland function in the residents of Magadan Region
Gorbachev AL, Lugovaia EA, Ryzhak GA, Khavinson VKh, 2005, Advances in Gerontology - Peptide Regulation of Gene Expression: A Systematic Review
Khavinson V, Linkova N, Dyatlova A, et al., 2021, Molecules - Penetration of short fluorescence-labeled peptides into the nucleus
Fedoreyeva LI, Kireev II, Khavinson VKh, Vanyushin BF, 2011, Biochemistry (Moscow) - Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA
Fedoreyeva LI, Kireev II, Khavinson VKh, 2011, Biochemistry (Mosc)
Research Focus
Testicular function, Testosterone support, Anti-aging, Male reproductive health, Gonadal restoration
Verified Vendors Carrying Testagen
Frequently Asked Questions
What should researchers watch for with Testagen?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with Testagen?
Weeks 1–4 (reported in cited studies): subtle or no effects initially
How is Testagen typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →